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Edited by Vladimir SkulachevAbstract Under hypobaric hypoxia, antioxidant defenses of the
heart are stressed by the enhanced production of ROS. Mamma-
lian heart acclimatizes to hypoxia through altered gene expres-
sion, which we studied in murine heart exposed to 10 h of
acute hypobaric hypoxia (AHH), equivalent to 15000 ft, using
cDNA arrays. Functional classiﬁcation of genes with a >2-fold
change revealed a number of pro-oxidants like Cyba, Xdh,
Txnip, Ppp1r15b and antioxidants like Cat, Gpx1, Mt1, Mgst1.
Interestingly, the protein level of Cyba, a subunit of NADPH
oxidase, was markedly decreased in AHH exposed heart, sug-
gesting the involvement of some stress response pathways. The
AHH exposure also caused a signiﬁcant reduction (50%) in
the level of GSH (P < 0.05). The present study provides a retro-
spective insight on the cellular antioxidant defense mechanisms
under AHH.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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The environment at high-altitude (HA) is extreme, charac-
terized by hypobaric hypoxia. At HA, less oxygen is available
to terminally accept electrons from oxidative phosphorylation.
Hypoxia partially inhibits mitochondrial electron transport,
producing redox changes in the electron carriers and increase
the generation of reactive oxygen species (ROS) at mitochon-
drial complex III [1,2]. ROS are oxygen molecules in diﬀerent
states of oxidation or reduction, as well as, compounds of oxy-
gen with hydrogen and nitrogen. Oxygen is central to the gen-
eration of ROS, several of which play vital roles in vascular
physiology and pathophysiology; the most important of which
are nitric oxide (NO), superoxide ðO2 Þ, hydrogen peroxideAbbreviations: HA, high-altitude; ROS, reactive oxygen species; AHH,
acute hypobaric hypoxia; LPO, lipid peroxidation; MDA, malonalde-
hyde
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) [3,4]. ROS-linked injury
is mainly due to hydroxyl radical (OH), produced by the
Fenton reaction, i.e. H2O2 + Fe
2+ﬁ OH + OH + Fe3+ [5].
Under aerobic conditions, most of free iron ions are in the oxi-
dized form (Fe3+). However, under anaerobic conditions Fe2+
autoxidation ceases and Fe3+ is immediately reduced to Fe2+.
The appearance of Fe2+ becomes dangerous as re-oxygenation
activates the Fenton reaction and results in OH formation
[6].
In acute HA exposure, current evidence from diverse studies
of both human and animal models indicates that hypoxia de-
fenses are initiated by several oxygen-sensing and signal trans-
duction pathways [7]. Mammals have evolved a sophisticated
physiological network to maintain oxygen homeostasis at the
tissue level that involves the capture, binding, transport and
delivery of molecular oxygen [8]. Since the mammalian heart
is an obligate aerobic organ, a constant supply of oxygen is
indispensable to sustain cardiac function and viability [9].
When the supply fails to match myocardial demand cardiac
contractile dysfunction occurs, and prolongation of this mis-
match may lead to apoptosis and necrosis [10].
Gene expression studies of mouse heart after chronic con-
stant or intermittent hypoxia have been explored [11]; how-
ever, eﬀects of acute hypobaric hypoxia (AHH) on murine
heart have been explored for the ﬁrst time in this study. The
changes in gene expression in heart of mice exposed to 10 h
of hypobaric hypoxia were evaluated by cDNA arrays and val-
idated by real time PCR. The outcome was further conﬁrmed
at post-translational level by immunoblot. The speciﬁc activity
of antioxidant enzymes, lipid peroxidation (LPO) and reduced
glutathione (GSH) levels were also assayed in the hypoxic
heart. Our results revealed the eﬀect of AHH on the transcript
and protein levels of pro-oxidants and antioxidants. The level
of reduced glutathione was found to be signiﬁcantly decreased
which may be the consequence of reduced synthesis along with
its increased utilization.2. Materials and methods
2.1. Exposure of mice to hypobaric hypoxia and RNA isolation
The study was carried out on male Swiss albino mice (8-week-old)
housed in clean cages with food and water available ad libitum. Five
mice were exposed for a period of 10 h to a simulated altitude of
4570 m (15000 ft) by maintaining the pressure in the decompression
chamber at 426 mm Hg. Equal numbers of control mice were main-
tained at normal atmospheric pressure (760 mm Hg) for 10 h in theblished by Elsevier B.V. All rights reserved.
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at 25 ± 2 C. At the end of the exposure the mice were sacriﬁced by cer-
vical dislocation. The hearts were removed and parts of it were pro-
cessed immediately for total RNA isolation using TRIzol reagent
(Invitrogen, USA). The animal ethics committee of the institute
approved all the animal procedures.
2.2. Microarray experiments
Equal amount of total RNA was pooled from the ﬁve mice to give a
total of 6 lg for each group. Pooled total RNA was labeled using the
Micromax NEN TSA labeling kit (Perkin-Elmer Life Sciences, USA).
Fluorescein and Biotin labeled cDNA probes were synthesized and
puriﬁed using isopropyl alcohol precipitation. The cDNA probes were
mixed and simultaneously hybridized to 15 k mouse cDNA arrays
(The Microarray Center, Clinical Genomics Center, University Health
Network, Toronto, Canada) in an overnight incubation at 65 C. The
15 k double-spotted array contained 15264 sequence-veriﬁed mouse
ESTs procured from the National Institute of Aging (NIA). The
probes were detected using streptavidin and anti-ﬂuorescein antibody
conjugated to horse-radish peroxidase that catalyzes the deposition
of Cy5 and Cy3 labeled tyramide, respectively. The microarrays were
scanned and image analysis was performed using GenePix Professional
4200A scanner. GenePix result ﬁles (.gpr) were then transferred to
TIGR Express Converter to generate TIGR MultiExperiment Viewer
ﬁle (.mev) as output. Data normalization (lowess), ﬂagging, ﬁltering
and ﬂip dye consistency check was performed using TIGR MIDAS.
Normalized and ﬁltered expression ﬁles were analysed using TIGR
MeV [12]. Genes showing consistency between dye swap experiments
and upregulated or downregulated at and more than twofold were se-
lected. Onto-Express [13] was used to functionally classify the selected
genes according to the following Gene-Ontology (GO) categories: bio-
logical process; cellular role; and molecular function.2.3. Real time PCR
Total RNA as pooled above was reverse transcribed to yield single
strand cDNA using First-Strand cDNA Synthesis kit (Amersham
Biosciences, UK). Primers for real time PCR were designed for the
selected genes using the Primer Express software (Perkin-Elmer
Applied Biosystems) and are listed in Supplementary Table S1. Real
time PCR was performed on ABI Prism 7300 Sequence Detection Sys-
tem (Applied Biosystems, USA) using SYBR Green PCR Master Mix
(Applied Biosystems) as described previously [14]. The PCR reactions
were performed in triplicate for each gene. Relative transcript quanti-
ties were calculated using the DDCt method with b-actin (ACTB) as the
endogenous reference gene ampliﬁed from the samples.
2.4. Biochemical characterization of AHH exposed heart
2.4.1. Preparation of tissue samples. Portions of hearts were rinsed
in ice cold PBS (pH 7.4), weighed and a 10% (w/v) tissue homogenate
was prepared in ice-cold phosphate buﬀer (0.1 M, pH 7.4). The
homogenate was centrifuged and the resulting supernatant was used
for all the bioassays. Protein content was quantiﬁed by Bradford assay
(Bio-Rad Laboratories, CA) with BSA as the standard. All the assays
were performed on SpectraMax Plus 384 spectrophotometer (Molecu-
lar Devices, USA). Intra- and inter-assay coeﬃcients of variation were
less than 10%.
2.4.2. Lipid peroxidation assay. LPO was assayed based on the
method of Wright et al. [15]. The amount of malonaldehyde (MDA)
formed in each of the samples was measured in the supernatant at
535 nm. The amount of MDA formed was expressed as nmol MDA
formed/h/g tissue at 37 C.
2.4.3. Estimation of enzyme activities. Superoxide dismutase (Sod)
activity was assayed according to the method of Marklund and Markl-
und [16]. Changes in the absorbance were recorded at 420 nm. In brief,
the inhibition of autoxidation of pyrogallol was measured as a function
of time. The amount of enzyme required to obtain 50% inhibition was
considered equivalent to one unit of Sod activity. Catalase (Cat) activ-
ity was assayed by the method of Claiborne [17]. Change in absorbance
was recorded at 240 nm and enzyme activity was calculated in terms of
lmol H2O2 consumed/min/mg protein. Glutathione peroxidase (Gpx)
activity was assayed based on the method of Mohandas et al. [18]. Oxi-
dation of NADPH was recorded at 340 nm at 30 s intervals for 3 min
and the enzyme activity was expressed as nmol NADPH oxidized/min/
mg protein. Glutathione reductase (Gsr) activity was quantitated bymeasuring the disappearance of NADPH at 340 nm and was calculated
as nmol NADPH oxidized/min/mg protein [18]. Glutathione S-trans-
ferase activity was assayed according to the method of Habig et al.
[19]. The changes in absorbance were recorded at 340 nm and enzyme
activity was calculated as nmol CDNB conjugate formed/min/mg pro-
tein.
2.4.4. Reduced glutathione and total thiol estimation. GSH content
was measured by the method of Jollow et al. [20]. The absorbance
was measured at 412 nm. GSH content was calculated and expressed
as nmoles of GSH/ mg of sample protein. The total thiol (TSH) con-
tent in the tissue homogenate was determined using the method of Sed-
lak and Lindsay [21] and expressed as lmol of thiol/mg of protein.
2.5. Western blotting
Tissues were ground in liquid nitrogen, sonicated in lysis buﬀer (7 M
urea, 2 M thiourea, 2% DTT, 4% CHAPS and protease inhibitor cock-
tail) and centrifuged to obtain supernatant. The protein content in the
supernatant was determined by Bradford assay (Bio-Rad Laborato-
ries, CA). 50 lg of each protein sample was loaded and resolved on
15% SDS–PAGE and transferred to Hybond ECL membrane (Amer-
sham Bioscience). The membrane was blocked with 5% (w/v) nonfat
milk at room temperature for 2 h and incubated with rabbit polyclonal
antibody against Cyba (1:1000, Santa Cruz Biotechnology Inc., USA),
Sod1 (1:5000, Santa Cruz Biotechnology Inc.), Hmox1 (1:2000, Stress-
gen, USA) and mouse polyclonal antibody against a-tubulin (1:1000,
Santa Cruz Biotechnology Inc.) at room temperature for 1 h. After
washing with phosphate buﬀered saline with 0.1% Tween 20 (PBS-
T), the membrane was incubated with horseradish peroxidase-conju-
gated anti-rabbit antibody (1:20000, Sigma, USA) and anti-mouse
antibody (1:5000, Sigma) at room temperature for 1 h. After washing
in PBS-T, the bands were visualized with ECL-Plus kit (Amersham
Bioscience) and 4-chloro-1-naphthol (for a-tubulin) in accordance with
the manufacturer’s instructions.
2.6. Statistical analysis
Statistical analysis was carried out using one-way ANOVA and
P values less than 0.05 were regarded as signiﬁcant.3. Results and discussion
3.1. Diﬀerential expression analysis
The expression proﬁle of the murine heart exposed to 10 h of
hypobaric hypoxia revealed a large number of diﬀerentially
regulated genes. However, only those genes that passed the
quality control criteria and showed consistency in the experi-
ments were selected. Further, using 2-fold change as a thresh-
old we found 268 upregulated genes and 292 downregulated
genes. We used ontology-based tools to assign functional
category to the entire list of 560 genes (Supplementary Table
S2). Interestingly, the Onto-Express output revealed a number
of genes involved in oxidative stress to be diﬀerentially regu-
lated under the hypoxic conditions. We have also found a
2.21-fold increase in the transcription of hypoxia inducible
factor 1, alpha subunit (Hif1a), the oxygen-regulated subunit
of Hif1 transcription factor that regulates the transcription
of genes involved in oxygen homeostasis in response to
hypoxia. Additionally, genes involved in methionine metabo-
lism and taurine metabolism too were noticeably elevated.
Few of the microarray results were validated by real time
PCR (Table 1). The trend of expression proﬁle of the genes
was same as those obtained by microarray analysis, although,
the amplitude of change diﬀered between the two methods.
The role of the analyzed genes in ROS generation and its uti-
lization has been constructed with the help of GenMAPP [22]
software (Fig. 1). Based on our ﬁndings an attempt has been
made to segregate the genes according to their function and
compare with the available literature.
Table 1
Comparison of fold change in AHH versus control mice obtained from
microarray and real time PCR experiments
Gene symbol Gene name Fold change
Microarray Real timeb
Cyba Cytochrome b-245,
alpha polypeptide
2.2 1.2
Hmox1 Heme oxygenase 1 –a 1.9
Cat Catalase 4.1 1.8
Sod1 Superoxide dismutase 1 1.7 1.2
Mat1a Methionine
adenosyltransferase
I, alpha
26.2 139.3
Cdo1 Cysteine dioxygenase 1 12.0 3.7
aFlagged oﬀ in microarray analysis, i.e. spot data was excluded in the
array data analysis.
bReal time PCR data represent the mean fold change.
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3.2.1. Cyba, Xdh/XO and Ppp1r15b. The AHH exposure
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xanthine dehydrogenase (Xdh) and 2-fold decrease in the
transcript levels of cytochrome b-245, alpha polypeptide
(Cyba), as revealed by the microarray results.
Cardiac tissues are rich source of ROS and the enzymatic
sources capable of generating O2 in the vascular tissues
include NADPH oxidase and xanthine oxidase (XO). Cyba
is an essential subunit of NADPH oxidase, an enzyme consid-
ered to be a major source of O2 in cardiac cells catalyzing the
one-electron reduction of oxygen using NADH or NADPH as
the electron donor. Like the phagocytic NADPH oxidases, the
vascular NADPH oxidases are multicomponent enzymes com-
posed of two membrane-associated proteins (Nox homologues
and Cyba) and three cytosolic subunits [23]. Although real
time PCR analysis of Cyba showed no change (1.25-fold) in
the transcript levels (Table 1), we observed marked decrease
in the protein levels of Cyba in the AHH exposed heart
(Fig. 2). A study has shown that induction of heme oxygenase
1 (Hmox1), the rate-limiting enzyme of heme degradation
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Fig. 2. Immunoblot and quantitative analysis for Cyba, Sod1, Hmox1
and Alpha-tubulin (loading control) protein levels in control and AHH
exposed mice. The immunoblots were repeated thrice and the images
shown are the best representation of the data. The graphical
representation shows the relative integrated densitometry values
(IDV) quantiﬁed and normalized by that of Alpha-tubulin signal
using AlphaEaseFC software. Values are expressed as a percentage of
those obtained in control group and represent means ± S.D.
4580 J. Karar et al. / FEBS Letters 581 (2007) 4577–4582beta polypeptide (Cybb/Nox2) and Cyba, without changes at
the mRNA level [24]. We investigated the changes in the
mRNA levels of Hmox1 by real time PCR and found 1.88-fold
increase (Table 1) in its transcript levels. Our immunoblot re-
sults revealed decrease in the protein levels of Hmox1 in the
AHH exposed heart (Fig. 2) which is in agreement with some
of the earlier reports in certain human cell lines [25,26]. Hence
the decrease in the protein levels of Cyba could be due to some
regulatory factors other than Hmox1 and needs to be explored
in detail.
Ppp1r15b dephosphorylates eukaryotic translation initiation
factor 2a (eIF2a) and it is reported that blocking Ppp1r15b
expression protects cells from oxidative stress. The 2.21-fold
upregulation of Ppp1r15b, a short-lived protein whose levels
depend on continuous translation of its mRNA [27] cannot
be ignored. When Xdh is converted to XO, molecular oxygen
accepts electrons resulting in the generation of O2 or H2O2
[28]. It has also been reported that hypoxia increases the tran-
script levels as well as the activity of Xdh/XO in bovine endo-
thelial cells [29] and similarly we also observed a 2.86-fold
increase in the transcript levels of Xdh in AHH. Hence, the0
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Fig. 3. Eﬀect of AHH on the (A) Lipid peroxidation (LPO) levels, (B) Enzy
(TSH) content in murine heart. Values are expressed as a percentage of those
repeated twice and the intra- and inter-assay coeﬃcients of variation were lesupregulation in the transcript levels of Ppp1r15b and Xdh
are suggestive of enhanced oxidative stress in the AHH heart.
3.2.2. Lipid peroxidation. Acute hypoxia did increase the
levels of MDA but not signiﬁcantly (Fig. 3A). MDA, the
end product of LPO indicates the presence of free radicals
and LPO-induced cardiotoxicity. Formation of LPO products
leads to propagation of free radical reactions as can be see in
Figure 1. The extent of peroxidative injury mediated by LPO
levels can determine whether a stressed cell will either survive
or succumb via apoptosis or necrosis [30]. Relatively low
LPO stress as observed in response to AHHmight trigger cyto-
protective responses like induction of antioxidants.
3.3. Cellular antioxidant defenses
3.3.1. Sod, Cat and Gpx. We observed increase in the
mRNA levels of Sod1 (1.7-fold), Cat (4.13-fold) and Gpx1
(2.24-fold). The microarray results of Sod1 and Cat were val-
idated by real time PCR (Table 1). The generation of O2 re-
sults from one-electron reduction of oxygen by a variety of
oxidases as can be seen in Figure 1. O2 is rapidly dismutated
by Sod to the more stable ROS, H2O2 [31]. Both Cat and Gpx
catalyze the dismutation of H2O2 to H2O and molecular O2
[31]. The observed decrease in the enzyme activity of Sod,
Cat and Gpx (Fig. 3B) will lead to increased oxidative stress.
Hence, we speculate that the concomitant increase in the
mRNA levels of antioxidants could lead to increase in the
respective protein levels as observed in case of Sod1 (Fig. 2),
which might ultimately help in alleviating the oxidative stress.
3.3.2. Metallothioneins. The metallothionein 1 (Mt1) gene
showed 7.72-fold increase in the transcript levels. Metallo-
thioneins are potent antioxidants and the ability of Mt1 and
Mt2 to scavenge O2 generated from XO/Xdh system has been
demonstrated [32]. In the last few years, studies using cardiac-
speciﬁc, Mt-overexpressing transgenic mouse models have pro-
duced direct evidence to support the antioxidant and protec-
tive function of Mt from oxidative injury in the heart [33,34].
In this regard the increased transcription of Mt1 may protect
the AHH exposed heart from oxidative stress.
3.3.3. Thioredoxin system and peroxiredoxins. Thioredoxin
reductase (Txnrd) in conjunction with thioredoxin (Txn) is a
ubiquitous oxidoreductase system having antioxidant and re-
dox regulatory roles. Although, we observed no change in
the transcript levels of Txn1, there was a 1.54-fold increase
in the transcript levels of Txnrd1. Thioredoxin-interacting pro-Gsr Gst
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was found 2.24-fold upregulated and this could enhance oxida-
tive stress in the AHH heart. The microarray results revealed
no change in the transcript levels of peroxiredoxins (Prdx) like
Prdx1, Prdx3, Prdx4 and Prdx6. Txn reduces the oxidized form
of Prdx and the reduced Prdx scavenges ROS, such as H2O2
[31].
3.3.4. Total thiols and glutathione related systems. Thiol
compounds are a natural reservoir of the reductive capacity
of the cell. Thiols, together with non-enzymatic and enzymatic
factors, regulate the intracellular metabolism defending biolog-
ical structures and functions from the deleterious eﬀect of ROS
[36]. GSH, the most abundant non-protein thiol present in
mammalian cells serves as a sensitive marker of oxidative stress
and plays an important role in maintaining the integrity of the
cell system. Though, a decrease was observed in the total thiol
levels, the change was not signiﬁcant (Fig. 3C). However, sig-
niﬁcant depletion (50%) of GSH observed in the AHH heart
(Fig. 3C), could promote generation of ROS and oxidative
stress with cascade of eﬀects thereby aﬀecting the heart in re-
sponse to AHH. Also as there is no simultaneous increase in
the speciﬁc activity of Gsr (Fig. 3B) to replenish the GSH lev-
els, there will be generation of oxidative stress. No signiﬁcant
change was observed in the transcript levels of glutathione syn-
thetase (Gss) and Gsr which are responsible for the synthesis
and regeneration of GSH (Fig. 1). Additionally, there was
no change in the mRNA levels of glutaredoxin (Glrx), a class
of proteins known to protect against oxidative stress by cata-
lyzing reduction of protein mixed disulﬁdes with GSH [31].
The 2-fold transcriptional downregulation of glucose-6-
phosphate dehydrogenase (G6pd), a rate-limiting enzyme in
the pentose-phosphate pathway that generates NADPH in a
reaction coupled to the de novo production of cellular ribose
cannot be ignored as well. G6pd is required to maintain cyto-
solic GSH levels and is known to protect cardiomyocytes
against ROS injury [37]. Therefore, the transcriptional down-
regulation of G6pd in the AHH heart could be damaging to
the cardiomyocytes in the hypoxic state.
Within the alpha class of glutathione S-transferases (Gsts),
Gsta4 which has high catalytic eﬃciency in the conjugation
of 4-hydroxynonenal (4-HNE) and other genotoxic products
of lipid peroxidation [38] has shown 1.63-fold increase in the
transcript level, but no change was observed in the enzyme
activity of Gst (Fig. 3B). We have observed 5.98-fold induction
in the transcript levels of microsomal glutathione S-transferase
1 (Mgst1), which functions as a Gst as well as a peroxidase and
can remove harmful products of lipid peroxidation [39]. Fur-
ther, it has been shown that Mgst1 transcriptionally responds
to oxidative stress and thus the upregulation in its transcript
levels could play a protective role for intracellular membranes
against oxidative stress in AHH heart.
3.3.5. Homocysteine and taurine metabolism: Mat1a, Mat2a,
Ahcy and Cdo1. The transcript levels of methionine adenosyl-
transferase I, alpha (Mat1a) and S-adenosylhomocysteine
hydrolase (Ahcy), involved in homocysteine metabolism in-
creased signiﬁcantly. In mammals there are 2 genes encoding
Mats: Mat1a and Mat2a. Mat1a is expressed mostly in liver,
whereas Mat2a shows a wider distribution and is responsible
for S-adenosylmethionine synthesis in extrahepatic tissues
[40]. Though, there was no signiﬁcant change in the levels of
Mat2a, surprisingly there was >26-fold induction in the levels
of Mat1a. The microarray results for Mat1a were validated byreal time PCR. Though, the amplitude of change was diﬀerent
between the methods, the real time PCR conﬁrms the induc-
tion (139-fold) of Mat1a (Table 1). Since homocysteine can
exert a wide range of physiological eﬀects in the heart, the
increase in the transcription of Mat1a (26.21-fold) and Ahcy
(3.63-fold) certainly holds signiﬁcance with respect to oxidative
stress in the AHH heart. Microarray data showed >12-fold
induction of cysteine dioxygenase 1 (Cdo1), while the real time
PCR indicated 4-fold induction in its transcript levels (Table
1). As it can be seen in Figure 1, Cdo1 is involved in the syn-
thesis of taurine (2-amino ethane sulphonic acid). In the heart,
taurine comprises up to 60% of the total free amino acid pool.
Taurine serves several physiological and metabolic functions
and is known to play a protective role in hypoxia due to its
antioxidant properties [41]. Hence an increase in the transcrip-
tion of Cdo1 could be beneﬁcial to the AHH heart.4. Concluding remarks
The study has revealed change in the transcript and protein
levels of several important genes in response to AHH and
provides information about the redox status of the murine
heart in response to AHH as well. The eﬀects of ROS depend
not only upon the concentration of pro-oxidant molecules
generated but also the tissue oxidant defense reserve, which
has to combat the oxidative stress to maintain homeostasis.
The present study has revealed that AHH decreases the antiox-
idant enzyme activities, GSH and TSH levels. We found
decrease in protein levels of Cyba, a subunit of NADPH oxi-
dase, which is a major ROS generator in the heart. It, there-
fore, becomes imperative to explore the mechanism involved
in the downregulation of Cyba and whether it helps in decreas-
ing the stress. This could be one of the favored mechanisms in
heart to operate at low oxygen tension. In addition, investiga-
tion of these genes at diﬀerent degrees of hypobaric hypoxia
and multiple time points would provide valuable insights into
understanding free-radical-mediated damage during HA accli-
matization.
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